Molecular genetics of cutaneous lymphomas.
The underlying molecular basis of primary cutaneous lymphomas has not yet been clarified. However, abnormalities of cell cycle control genes and well-defined tumor suppressor genes such as p53 are common and may contribute to disease progression and treatment resistance. Biallelic inactivation of tumor suppressor genes usually occurs by a combination of deletion, point mutation, and/or promotor hypermethylation. The detection of UVB-specific mutations of p53 requires confirmation but may have important implications for the management of patients with mycosis fungoides. Molecular cytogenetic studies have identified common regions of chromosomal deletion and amplification, which suggests the presence and location of genes that are of critical importance in the pathogenesis of cutaneous lymphoma.
Whittaker
S
S
Skin Tumour Unit, St. John's Institute of Dermatology, St. Thomas' Hospital, London, UK. seanwhittaker@doctors.org.uk
D002869:Chromosome Aberrations; D016147:Genes, Tumor Suppressor; D016158:Genes, p53; D006801:Humans; D006824:Hybridization, Genetic; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D019656:Loss of Heterozygosity; D016410:Lymphoma, T-Cell, Cutaneous / Q000235:genetics*; D009154:Mutation; D012878:Skin Neoplasms / Q000235:genetics*